GIA
GILD icon

Gladstone Institutional Advisory’s Gilead Sciences GILD Stock Holding History

Gladstone Institutional Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
10,002
+4,424
+79% +$583K 0.04% 370
2026
Q1 		$778K Sell
5,578
-4,208
-43% -$589K 0.03% 435
2025
Q4 		$1.2M Buy
9,786
+166
+2% +$20.2K 0.05% 337
2025
Q3 		$1.07M Buy
9,620
+1,301
+16% +$148K 0.04% 353
2025
Q2 		$922K Buy
8,319
+43
+0.5% +$4.58K 0.04% 359
2025
Q1 		$927K Buy
8,276
+4,661
+129% +$481K 0.04% 342
2024
Q4 		$334K Sell
3,615
-289
-7% -$26K 0.02% 557
2024
Q3 		$327K Sell
3,904
-9,014
-70% -$688K 0.02% 554
2024
Q2 		$886K Buy
12,918
+182
+1% +$12.1K 0.05% 316
2024
Q1 		$933K Sell
12,736
-819
-6% -$63K 0.05% 298
2023
Q4 		$1.1M Sell
13,555
-252
-2% -$19.6K 0.06% 277
2023
Q3 		$1.03M Buy
13,807
+511
+4% +$39.3K 0.07% 263
2023
Q2 		$1.02M Sell
13,296
-97
-0.7% -$7.74K 0.06% 271
2023
Q1 		$1.11M Sell
13,393
-2,158
-14% -$179K 0.07% 263
2022
Q4 		$1.34M Buy
15,551
+452
+3% +$35.8K 0.09% 240
2022
Q3 		$931K Buy
15,099
+1,180
+8% +$74.4K 0.07% 281
2022
Q2 		$860K Buy
13,919
+1,084
+8% +$67.1K 0.07% 302
2022
Q1 		$763K Buy
12,835
+1,050
+9% +$67.1K 0.05% 347
2021
Q4 		$856K Buy
+11,785
New +$812K 0.07% 288
2020
Q4 		– Sell
-5,204
Closed -$329K – 308
2020
Q3 		$329K Buy
5,204
+1,497
+40% +$104K 0.08% 196
2020
Q2 		$285K Sell
3,707
-4,631
-56% -$355K 0.07% 180
2020
Q1 		$623K Buy
8,338
+4,837
+138% +$334K 0.16% 126
2019
Q4 		$227K Sell
3,501
-497
-12% -$32.4K 0.06% 241
2019
Q3 		$253K Buy
+3,998
New +$261K 0.06% 231

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gladstone Institutional Advisory's GILD Position: Q2 2026 in Review

Gladstone Institutional Advisory increased its Gilead Sciences (GILD) stake by 79% in Q2 2026, buying an estimated $583K and bringing the position to 10,002 shares worth $1.26M. The position accounts for 0.04% of the portfolio, ranked #370.

Gladstone Institutional Advisory first reported a position in GILD in Q3 2019 and has held it in 24 quarters since. The position peaked at $1.34M in Q4 2022. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Gladstone Institutional Advisory held 10,002 shares of Gilead Sciences worth $1.26M as of Q2 2026.
  • Gladstone Institutional Advisory bought 4,424 Gilead Sciences shares in Q2 2026, an estimated $583K.
  • Gilead Sciences made up 0.04% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #370 holding.
  • Gladstone Institutional Advisory first reported a position in Gilead Sciences in Q3 2019 and has held it in 24 quarters since.
  • Gladstone Institutional Advisory's Gilead Sciences position peaked at $1.34M in Q4 2022.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.